- Joined
- Apr 27, 2006
- Messages
- 22
- Reaction score
- 0
I was curious to see how much this domain name is worth. NRP-104 is a new ADHD drug coming out on the market late 2006/early 2007 to help kids with ADHD. The drug is suppose to surpass Ridalin, and economic forecasters are projecting huge worldwide sales. Here are some links:
http://72.14.209.104/search?q=cache...104&hl=en&gl=us&ct=clnk&cd=1&client=firefox-a
http://www.albmolecular.com/news/press/pr202.html
NRP-104 Facts from this page:
-
NRP-104 achieves similar blood amphetamine levels
to current extended-release amphetamine products
-
NRP-104 demonstrates comparable efficacy to Adderall
XR
-
SWOT analysis of NRP-104
-
NRP-104 â the first non-scheduled stimulant
-
Equivalent efficacy to Adderall XR in treating children
and adults
-
NRP-104 will become the market-leading amphetamine
by 2010
http://72.14.209.104/search?q=cache...104&hl=en&gl=us&ct=clnk&cd=1&client=firefox-a
http://www.albmolecular.com/news/press/pr202.html
NRP-104 Facts from this page:
-
NRP-104 achieves similar blood amphetamine levels
to current extended-release amphetamine products
-
NRP-104 demonstrates comparable efficacy to Adderall
XR
-
SWOT analysis of NRP-104
-
NRP-104 â the first non-scheduled stimulant
-
Equivalent efficacy to Adderall XR in treating children
and adults
-
NRP-104 will become the market-leading amphetamine
by 2010